Skip to main content
ECG
NYSE Real Estate & Construction

Everus Crushes Q2 Estimates and Lifts 2026 Outlook on Record Backlog and 34% Revenue Jump

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Homebuilder Stocks · Real Estate
Sentiment info
Positive
Importance info
8
Price
$148.45
Mkt Cap
$6.95B
52W Low
$69.61
52W High
$171.577
52W Position info
113% above low
Off High info
13% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ECG has more than doubled off its 52-week low of $69.61.

Summary

Record Q2 results featured a 34% revenue increase to $1.23B and a 53% EBITDA jump to $128.6M, prompting a full-year guidance raise and ending with a record $4.55B backlog.


Key Events · Earnings and Guidance · ECG

  • Record Q2 Revenue and Profitability

    Revenue reached $1.23B (up 33.7% YoY), net income rose to $83.9M (up 58.9%), and diluted EPS hit $1.64 (up 59.2%). Organic revenue growth was 30%.

  • EBITDA Surge and Margin Expansion

    EBITDA of $128.6M (up 52.7% YoY) drove margin expansion to 10.4% from 9.1%, reflecting strong project execution and operating leverage.

  • Record Backlog Provides Visibility

    Backlog climbed to $4.55B, up 41% from year-end 2025 and 52.8% from June 2025, supported by over $2B in Q2 bookings across data center, hospitality, and high-tech end markets.

  • Raised Full-Year 2026 Guidance

    Revenue guidance was raised to $4.5B-$4.7B (from $4.3B-$4.4B) and EBITDA guidance to $410M-$425M (from $345M-$360M), reflecting strong first-half execution and demand visibility.


Analysis · ECG · Real Estate & Construction

A standout quarter saw revenue climb 34% to $1.23B and EBITDA surge 53% to $128.6M—both records. Organic growth hit 30%, fueled by data center and commercial demand. Backlog swelled to $4.55B, up 53% year-over-year, offering robust visibility. Reflecting confidence in sustained momentum, management raised full-year revenue guidance by roughly 7% and EBITDA guidance by about 19% at the midpoint. The balance sheet remains pristine with 0.3x net leverage and $167M in free cash flow, providing ample firepower for the pending $295M Epsilon acquisition. This print affirms the thesis and materially de-risks the growth story.

At the time of this filing, ECG was trading at $148.45 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.9B. The 52-week trading range was $69.61 to $171.58. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ECG - Latest Insights

ECG
Aug 04, 2026, 4:30 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $151.01
Real-time Price: $136.60 info
Change: -$14.41 (-10%) info
Market Cap: $6.95B info
ECG
Jul 31, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $122.00
Real-time Price: $136.60 info
Change: +$14.60 (+12%) info
Market Cap: $6.95B info
ECG
Jul 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $122.00
Real-time Price: $136.60 info
Change: +$14.60 (+12%) info
Market Cap: $6.95B info
ECG
May 06, 2026, 4:42 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $168.75
Real-time Price: $136.60 info
Change: -$32.15 (-19%) info
Market Cap: $6.95B info
ECG
May 05, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $171.00
Real-time Price: $136.60 info
Change: -$34.40 (-20%) info
Market Cap: $6.95B info